Ruthsarian
Home
Sitemap
Q & A
Notice Board
PhEpi & PhV activities
Research Funding
Conferences & meetings
Recruitment
Links
Contact Us
Links to Studies
Status
Official Title
Lead Investigator
Last Updated
Finalised
Implementation of EU risk minimisation measures for medicinal products in clinical guidelines
Dr Helga Gardarsdottir
28/11/2023
Finalised
Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products: utilization and prescribing trends
Dr Miriam Sturkenboom
05/09/2023
Finalised
Cohort Event Monitoring of safety of COVID-19 vaccines in special populations (pregnant and lactating women, children and adolescents, immunocompromised, people with history of allergy, people with prior SARS-CoV-2 infection)
Professor Gianluca Trifirò
31/08/2023
Finalised
Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources
Professor Miriam Sturkenboom
31/08/2023
Finalised
Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen
Dr Elisa MartÃn Merino
24/04/2023
Finalised
Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines
Professor Miriam Sturkenboom
09/01/2023
Finalised
Coverage of COVID-19 vaccines in electronic healthcare databases: a protocol template from the ACCESS project
Professor Miriam Sturkenboom
09/01/2023
Finalised
ACCESS template protocol for safety of COVID-19 vaccines
Professor Miriam Sturkenboom
09/01/2023
Finalised
Cohort monitoring of Adverse Events of Special Interest and COVID-19 diagnoses prior to and after COVID-19 vaccination
Professor Miriam Sturkenboom
09/01/2023
Finalised
Strengthening Use of Real-World Data in Medicines Development: Metadata for Data Discoverability and Study Replicability
Dr Susana Perez-Gutthann
18/10/2022
Finalised
ACCESS template protocols for effectiveness of COVID-19 vaccines
Professor Miriam Sturkenboom
02/02/2021
Finalised
Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of pertussis and pertussis related outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children
Professor Miriam Sturkenboom
27/11/2017
Ongoing
A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources (COVID-19)
Dr Cristina Rebordosa
12/05/2023
Ongoing
An Observational Post-Authorization Safety Study to Assess the Safety of Ad26.COV2.S Using European Healthcare Data through VAC4EU (COVID-19)
Dr Fariba Ahmadizar
08/05/2023
Ongoing
CONSIGN study: COVID-19 infection and medicines in pregnancy - a multinational registry based study
Professor Hedvig Nordeng
16/08/2022
Ongoing
COVID-19 infections and medicines in pregnancy- the INOSS collaboration
Professor Kitty Bloemenkamp
29/04/2021
Ongoing
A Real World Evidence prospective cohort study in the management of metastatic colorectal cancer: a clinical and patient perspective
Professor Miriam Koopman
25/03/2021
Planned
Description of international collaboration in the area of medicines use and effects in COVID-19 affected pregnancies (CONSIGN-International))
Professor Miriam Sturkenboom
29/09/2022
Planned
Exposure and coverage to routine schedule vaccines in different EU countries
Professor Miriam Sturkenboom
02/02/2019
News
About Us
ENCePP Documents
Training in PhEpi and PV
Code of Conduct
Standards & Guidances
ENCePP Study Seal
Public Consultation
Glossary of terms
Resources Database
Partners forum
EU PAS Register
About EU PAS Register